Inventor · Bainbridge Island, WA, US

Michael Wittekind

26Patents
9h-index
34Co-inventors
75Inventor score

Filing activity: Jan 6, 2000 → Sep 2, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8592562B2 Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects Chemistry; Metallurgy 268 Active
US7858739B2 Inhibitors of type 2 vascular endothelial growth factor receptors Chemistry; Metallurgy 62 Active
US7847062B2 Pharmacokinetic modulation and compositions for modified FN3 polypeptides Chemistry; Metallurgy 59 Active
US8324362B2 Nucleic acid encoding 10FN3 polypeptide inhibitors of Type 2 vascular endothelial growth factor receptors Chemistry; Metallurgy 57 Active
US8609613B2 Methods of inhibiting type 2 vascular endothelial growth factor receptors using polypeptides Chemistry; Metallurgy 35 Active
US9328157B2 Inhibitors of type 2 vascular endothelial growth factor receptors Chemistry; Metallurgy 26 Active
US9862758B2 Inhibitors of type 2 vascular endothelial growth factor receptors Chemistry; Metallurgy 20 Active
US8193322B2 Methods for generating monovalent IgG Chemistry; Metallurgy 19 Active
US6333186A Modified forms of Hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease: inhibitor complexes Chemistry; Metallurgy 11 Expired
US6800456B2 Modified forms of hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease:inhibitor complexes Chemistry; Metallurgy 5 Expired
US11474111B2 Methods for characterizing and engineering protein-protein interactions Chemistry; Metallurgy 5 Active
US9499594B2 Biofilm prevention, disruption and treatment with bacteriophage lysin Emerging Cross-Sectional Technologies 5 Active
US10744189B2 Lysin polypeptides active against Gram-negative bacteria Emerging Cross-Sectional Technologies 5 Active
US11726097B2 Methods for characterizing and engineering protein-protein interactions Chemistry; Metallurgy 3 Active
US9718875B2 Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy Chemistry; Metallurgy 2 Active
US9889181B2 Bacteriophage lysin and antibiotic combinations against gram positive bacteria Emerging Cross-Sectional Technologies 1 Active
US11413334B2 Lysin polypeptides active against Gram-negative bacteria Emerging Cross-Sectional Technologies 1 Active
US10995131B2 Libraries of modified fibronectin type III tenth domain-containing polypeptides Chemistry; Metallurgy 1 Active
US11357833B2 Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby Emerging Cross-Sectional Technologies 0 Active
US12144845B2 Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby Emerging Cross-Sectional Technologies 0 Active
US10813983B2 Bacteriophage lysin and antibiotic combinations against gram positive bacteria Emerging Cross-Sectional Technologies 0 Active
US11524046B2 Biofilm prevention, disruption and treatment with bacteriophage lysin Emerging Cross-Sectional Technologies 0 Active
US10639370B2 Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof Chemistry; Metallurgy 0 Active
US11827693B2 Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy Chemistry; Metallurgy 0 Active
US11246928B2 Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.